Close X
Attorney Spotlight

Find out which two countries Cheryl Palmeri gets the most questions about related to International Trade in today's market? Find out more>


Close X


Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

Aggressive False Claims Actions, Medical Necessity Determinations and Individual Liability Charges


July 31, 2012

Bass, Berry & Sims healthcare fraud attorney, Anna Grizzle, will participate on the panel discussion, "Aggressive False Claims Actions, Medical Necessity Determinations and Individual Liability Charges" at the American Conference Institute's Advanced Forum on Healthcare Provider Disputes and Litigation on Tuesday, July 31. Assistant United States Attorney, Jeffrey W. Dickstein, will also participate in this panel discussion.

The topic of discussion will cover:

  • Minimizing your exposure to False Claims Act violations under Health Care Reform’s expanded statute
  • Examining the key considerations, strategies and timing involved in the motion practice and procedural issues when it becomes necessary to litigate a FCA case
  • Ensuring diagnosis codes are properly submitted so that the provider is reimbursed for services offered
  • Reporting overpayments to the government within a defined period of time to avoid increased monetary penalties
  • Top 5 things to do now to diminish your risk of a government investigation
  • Developing a risk adjustment model that withstands government scrutiny billing, medical necessity, and other fraud.
  • Determining if a procedure was medically necessary and who authorized its performance
  • Mitigating the risks of billing for services not provided, billing for a level of service not provided, or miscoding a claim to obtain reimbursement
  • Conducting due diligence assessments to safeguard the provider against anti-kickback and Stark Law violations Individual Accountability
  • Working through available defenses to a Park charge
  • Insulating yourself from liability in the government’s pursuit of individual providers for health care fraud
  • Preparing for the government’s increased focus on provider activity
  • Ensuring that service was provided within Medicare guidelines
  • Learning how to cope with corporate life under the government’s microscope
  • Representing yourself accurately and producing documents to avoid false claims or obstruction of justice allegations

For more information on this conference, please visit the ACI website.

Download Document - ACI Healthcare Provider Disputes and Litigation Conference Brochure

Related Professionals

Related Services


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.